Intellia Therapeutics (NTLA) EBITDA Margin Growth (3y) (2018 - 2026)
Intellia Therapeutics (NTLA) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
13,218.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
13,218.00 |
| Dec 31, 2025 |
40,551.00 |
| Sep 30, 2025 |
11,938.00 |
| Jun 30, 2025 |
1,458.00 |
| Mar 31, 2025 |
66,866.00 |
| Dec 31, 2024 |
-37,102.00 |
| Sep 30, 2024 |
2.25 Mn |
| Jun 30, 2024 |
-106,512.00 |
| Mar 31, 2024 |
34,298.00 |
| Dec 31, 2023 |
746,583.00 |
| Sep 30, 2023 |
-89,089.00 |
| Jun 30, 2023 |
-71,805.00 |
| Mar 31, 2023 |
-14,625.00 |
| Dec 31, 2022 |
-56,224.00 |
| Sep 30, 2022 |
-63,026.00 |
| Jun 30, 2022 |
-49,898.00 |
| Mar 31, 2022 |
-114,409.00 |
| Dec 31, 2021 |
-40,881.00 |
| Sep 30, 2021 |
-2.36 Mn |
| Jun 30, 2021 |
-76,107.00 |
